Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/medison-pharma-announces--agreement-with-regeneron-pharmaceuticals-to-commercialize-libtayo-cemiplimab-in-multiple-countries-302028359.html
https://www.fiercepharma.com/pharma/regeneron-hands-certain-european-libtayo-rights-medison-pharma
https://www.prnewswire.com/news-releases/ipsen-and-medison-pharma-announce-health-canada-approval-of-bylvay-odevixibat-for-the-treatment-of-pruritus-due-to-progressive-familial-intrahepatic-cholestasis-pfic-301986009.html
https://www.prnewswire.com/news-releases/medison-pharma-announces-public-formulary-listing-of-qinlock-ripretinib-in-canadian-provinces-ontario-and-quebec-for-advanced-gastrointestinal-stromal-tumor-gist-treatment-301942841.html
https://www.prnewswire.com/news-releases/alnylam-pharmaceuticals-and-medison-pharma-announce-the-expansion-of-their-collaboration-to-a-multi-regional-partnership-to-commercialize-rnai-therapeutics-301767790.html
https://www.prnewswire.com/news-releases/medison-pharma-announces-the-expansion-of-its-partnership-with-albireo-to-a-multi-regional-agreement-to-commercialize-odevixibat-in-canada-and-israel-301606428.html
https://www.prnewswire.com/news-releases/medison-pharma-announces-multi-regional-partnership-agreement-with-argenx-to-commercialize-efgartigimod-across-europe-and-israel-301561651.html
https://www.prnewswire.com/news-releases/medison-pharma-announces-extension-of-multi-territorial-agreement-with-immunocore-and-expansion-into-australia-and-new-zealand-301552771.html
https://www.prnewswire.com/news-releases/victor-papamoniodis-joins-medison-pharma-as-vp-international-markets-301464756.html